Ibandronate reduces osteolytic lesions but not tumor burden in a murine model of myeloma bone disease

Sarah L. Dallas, I. Ross Garrett, Babatunde O. Oyajobi, Mark R. Dallas, Brendan F. Boyce, Frieder Bauss, Jiri Radl, Gregory R. Mundy

Research output: Contribution to journalArticlepeer-review

114 Scopus citations

Fingerprint

Dive into the research topics of 'Ibandronate reduces osteolytic lesions but not tumor burden in a murine model of myeloma bone disease'. Together they form a unique fingerprint.

Medicine & Life Sciences